04 Aug 2022 by admin in UncategorizedComments NextCure Provides Business Update and Reports Second Quarter 2022 Financial Results
04 Aug 2022 by admin in UncategorizedComments Laronde Appoints John Mendlein as Chief Executive Officer
03 Aug 2022 by admin in UncategorizedComments Syros Receives Positive Opinion on Orphan Drug Designation from the European Medicines Agency for Tamibarotene for the Treatment of MDS
01 Aug 2022 by admin in UncategorizedComments Zenas BioPharma Obtains IND Approval in China for Phase 1/2 Study of ZB001 for the Treatment of Thyroid Eye Disease
01 Aug 2022 by admin in UncategorizedComments OriCell Therapeutics Raises Over $120 Million in Series B Financing
01 Aug 2022 by admin in UncategorizedComments KIRA PHARMACEUTICALS APPOINTS ANGELA YAN AS PRESIDENT OF CHINA AND ASIA DEVELOPMENT AND OPERATIONS
28 Jul 2022 by admin in UncategorizedComments KIRA PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG DESIGNATION FOR KP104, A BIFUNCTIONAL ANTIBODY FUSION PROTEIN, FOR THE TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
06 Jul 2022 by admin in UncategorizedComments Crescendo Biologics announces nomination of second proprietary clinical candidate from immuno-oncology Humabody VH development portfolio
06 Jul 2022 by admin in UncategorizedComments NextCure Announces Development of a Highly Specific Immunohistochemical Diagnostic for Siglec- 15-positive Tumors as reported in Laboratory Investigation
